Selective serotonin reuptake inhibitors and adverse pregnancy outcomes.

[1]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1941 .

[2]  M. Lindheimer,et al.  Medical Disorders during Pregnancy , 1952, The Indian Medical Gazette.

[3]  M. O’Hara,et al.  Prospective study of postpartum depression : Prevalence, course, and predictive factors , 1984 .

[4]  K. Bjøro,et al.  In Vitro Perfusion Studies on Human Umbilical Arteries: I. Vasoactive Effects of Serotonin, PGF2α and PGE2 , 1986, Acta obstetricia et gynecologica Scandinavica.

[5]  W. Stigelman,et al.  Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .

[6]  G. Koren,et al.  Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac) , 1993, JAMA.

[7]  G. Haugen.  THE VASOACTIVE EFFECTS OF SEROTONIN IN NORMAL AND SINGLE UMBILICAL ARTERY CORDS IN NORMOTENSIVE AND HYPERTENSIVE PREGNANCIES , 1996 .

[8]  K. Jones,et al.  Birth outcomes in pregnant women taking fluoxetine. , 1996, New England Journal of Medicine.

[9]  G. Koren,et al.  Neurodevelopment of children exposed in utero to antidepressant drugs , 1997, The New England journal of medicine.

[10]  K. Ormond,et al.  Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. , 1998, JAMA.

[11]  H. Sørensen,et al.  Improvement of drug exposure data in a registration of congenital anomalies. Pilot-study: pharmacist and mother as sources for drug exposure data during pregnancy. EuroMAP Group. Europen Medicine and Pregnancy Group. , 1999, Teratology.

[12]  A. Richter,et al.  Assessing the Saskatchewan database for outcomes research studies of depression and its treatment. , 2000, Journal of clinical epidemiology.

[13]  H. Nordeng,et al.  Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors , 2001, Acta paediatrica.

[14]  P. Beck,et al.  Health Databases in Saskatchewan , 2002 .

[15]  U. Ekblad,et al.  Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. , 2003, Archives of general psychiatry.

[16]  H. Hoyme,et al.  Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. , 2003, The Journal of pediatrics.

[17]  L. Altshuler,et al.  Birth outcomes after prenatal exposure to antidepressant medication. , 2003, American journal of obstetrics and gynecology.

[18]  P. S. Zeskind,et al.  Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. , 2004, Pediatrics.

[19]  M. Hotopf,et al.  Amitriptyline for inpatients and SSRIs for outpatients with depression? Systematic review and meta-regression analysis. , 2004, Pharmacopsychiatry.

[20]  D. Healy,et al.  trialsreview of randomised controlled selective serotonin reuptake inhibitors: Association between suicide attempts and , 2005 .

[21]  P. Hallberg,et al.  The Use of Selective Serotonin Reuptake Inhibitors During Pregnancy and Breast-feeding: A Review and Clinical Aspects , 2005, Journal of clinical psychopharmacology.

[22]  N. Kaciroti,et al.  Selective Serotonin Reuptake Inhibitor (SSRI) Use during Pregnancy and Effects on the Fetus and Newborn: A Meta-Analysis , 2005, Journal of Perinatology.

[23]  J. Friedman,et al.  Angiotensin II receptor antagonist treatment during pregnancy. , 2005, Birth defects research. Part A, Clinical and molecular teratology.

[24]  Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials , 2005, BMJ : British Medical Journal.

[25]  G. Koren,et al.  Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates? , 2005, Canadian Medical Association Journal.

[26]  Andrew Bate,et al.  Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis , 2005, The Lancet.

[27]  Andrés Martin,et al.  SSRIs and the developing brain , 2005, The Lancet.